 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on May 20, 2022 |
| Title |
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
May 17, 2022 |
| Last update date |
May 22, 2022 |
| Contact name |
Bic MSKCC |
| Organization name |
Memorial SLoan-Kettering Cancer Center
|
| Street address |
1275 York Ave.
|
| City |
New York |
| State/province |
NY |
| ZIP/Postal code |
10021 |
| Country |
USA |
| |
|
| Platforms (3) |
| GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (49)
|
| GSM6161301 |
Lymph_node_endogenous_VDJ |
| GSM6161302 |
Sample_RNA_Pt1,Pt2,Pt3,Pt4,Pt5,Pt6,Pt7,Pt8,Pt9,Pt10 |
| GSM6161303 |
Sample_HTO_Pt1,Pt2,Pt3,Pt4,Pt5,Pt6,Pt7,Pt8,Pt9,Pt10 |
| GSM6161304 |
Sample_VDJ_Pt1,Pt2,Pt3,Pt4,Pt5,Pt6,Pt7,Pt8,Pt9,Pt10 |
| GSM6161305 |
DPTCells_RNA_CD4+,CD8+,CD4+CD8+,CD8+CD4+ |
| GSM6161306 |
DPTCells_HTO_CD4+,CD8+,CD4+CD8+,CD8+CD4+ |
| GSM6161307 |
DPTCells_VDJ_CD4+,CD8+,CD4+CD8+,CD8+CD4+ |
| GSM6161317 |
T1 - Naïve Trp1 CD4+ |
| GSM6161318 |
T2 - Naïve Trp1 CD4+ |
| GSM6161319 |
T3 - Naïve Trp1 CD4+ |
| GSM6161320 |
T4 - Tumor Trp1 CD4+ |
| GSM6161321 |
T5 - Tumor Trp1 CD4+ |
| GSM6161322 |
T6 - Tumor Trp1 CD4+ |
| GSM6161323 |
T7 - Tumor Trp1 CD4+CD8+ |
| GSM6161324 |
T8 - Tumor Trp1 CD4+CD8+ |
| GSM6161325 |
T9 - Tumor Trp1 CD4+CD8+ |
| GSM6161326 |
P1 - Naïve Pmel CD8+ |
| GSM6161327 |
P2 - Naïve Pmel CD8+ |
| GSM6161328 |
P3 - Naïve Pmel CD8+ |
| GSM6161329 |
P4 - Tumor Pmel CD8+ |
| GSM6161330 |
P5 - Tumor Pmel CD8+ |
| GSM6161331 |
P6 - Tumor Pmel CD8+ |
| GSM6161332 |
P7 - Tumor Pmel CD8+CD4+ |
| GSM6161333 |
P8 - Tumor Pmel CD8+CD4+ |
| GSM6161334 |
P9 - Tumor Pmel CD8+CD4+ |
| GSM6161335 |
U_CD4 |
| GSM6161336 |
U_CD8 |
| GSM6161337 |
U_TDP |
| GSM6161338 |
T1 - ATAC-Seq - Naïve Trp1 CD4+ |
| GSM6161339 |
T2 - ATAC-Seq - Naïve Trp1 CD4+ |
| GSM6161340 |
T3 - ATAC-Seq - Naïve Trp1 CD4+ |
| GSM6161341 |
T4 - ATAC-Seq - Tumor Trp1 CD4+ |
| GSM6161342 |
T5 - ATAC-Seq - Tumor Trp1 CD4+ |
| GSM6161343 |
T6 - ATAC-Seq - Tumor Trp1 CD4+ |
| GSM6161344 |
T7 - ATAC-Seq - Tumor Trp1 CD4+CD8+ |
| GSM6161345 |
T8 - ATAC-Seq - Tumor Trp1 CD4+CD8+ |
| GSM6161346 |
T9 - ATAC-Seq - Tumor Trp1 CD4+CD8+ |
| GSM6161347 |
P1 - ATAC-Seq - Naïve Pmel CD8+ |
| GSM6161348 |
P2 - ATAC-Seq - Naïve Pmel CD8+ |
| GSM6161349 |
P3 - ATAC-Seq - Naïve Pmel CD8+ |
| GSM6161350 |
P4 - ATAC-Seq - Tumor Pmel CD8+ |
| GSM6161351 |
P5 - ATAC-Seq - Tumor Pmel CD8+ |
| GSM6161352 |
P6 - ATAC-Seq - Tumor Pmel CD8+ |
| GSM6161353 |
P7 - ATAC-Seq - Tumor Pmel CD8+CD4+ |
| GSM6161354 |
P8 - ATAC-Seq - Tumor Pmel CD8+CD4+ |
| GSM6161355 |
P9 - ATAC-Seq - Tumor Pmel CD8+CD4+ |
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE203182 |
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions (1) |
| GSE203183 |
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions (2) |
| GSE203184 |
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions (3) |
| GSE203186 |
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions (4) |
| GSE203187 |
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions (5) |
| GSE203188 |
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions (6) |
|
| Relations |
| BioProject |
PRJNA838977 |
|
|
|
|
 |
Less...
More...